• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

矛头蝮属蛇毒:某些生化和理化性质的比较以及对血小板功能的干扰

Bothrops sp. snake venoms: comparison of some biochemical and physicochemical properties and interference in platelet functions.

作者信息

Francischetti I M, Castro H C, Zingali R B, Carlini C R, Guimarães J A

机构信息

Departamento de Bioquímica Médica-ICB, Universidade Federal do Rio de Janeiro, Brazil.

出版信息

Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Jan;119(1):21-9. doi: 10.1016/s0742-8413(97)00163-1.

DOI:10.1016/s0742-8413(97)00163-1
PMID:9580495
Abstract

Procoagulant, proteolytic, phospholipase and platelet pro-aggregating and inhibiting activities were screened for pooled venoms of seven Bothrops species as well as Crotalus durissus terrificus and Lachesis muta snakes typical of the Brazilian territory. As reported by other authors, we also found that examination of the electrophoretic and gel filtration patterns of Bothrops snakes venoms could not be used for identification of the species of a given venom because of the lack of marked interspecific differences within the same genus. Our data indicated that B. cotiara, B. alternatus and B. atrox possess no platelet pro-aggregating activity, low inhibitory effect on platelet aggregation and very low or intermediate levels for the other activities. B. moojeni, B. neuwiedi and B. jararacussu whose venoms possess high procoagulant, platelet pro-aggregating and phospholipase activities are low in both proteolytic and platelet inhibitory activities. B. jararaca venom showed the highest inhibitory effect on platelet aggregation and very low platelet pro-aggregating activity. Compared with the Bothrops venoms studied, L. muta venom showed that highest proteolytic activity while C. d. terrificus venom presented remarkable high platelet pro-aggregating and phospholipase activities. In all venoms, proteolytic activity could be completely inhibited by EDTA (2 mM) alone. In contrast, the presence of phenylmethylsulfonyl fluoride (5 mM) inhibited partially the caseinolytic activity of all venoms, except that L. muta venom, which was almost completely blocked by this reagent. Altogether, these data confirm the presence of high levels of metalloproteinases in the venoms of Crotalinae snakes. Most of these enzymes are dependent of the availability of Ca2+, being much less the same concerning the presence of serine residues in their active sites. The data indicated that the presence and levels of procoagulant, azocaseinolytic and phospholipase A2 activities alone could not differentiated the species of the Bothrops venoms studied, particularly in the cases of B. jararaca, B. moojeni and B. atrox. However, the platelet inhibiting property of low doses of B. jararaca venom can be useful to differentiate it from B. moojeni venom. In the same way, the platelet pro-aggregating activity of high doses of B. jararaca venom may be used to distinguish it from B. atrox crude venom, otherwise very similar but incapable to activate platelets. In conclusion, our comparative screening of biological properties has indicated that platelet studies may serve as a tool to distinguish among venoms that otherwise behave biochemically in a very similar way. Although promising, the general applicability of platelet activation studies by snake venoms for classification or taxanomical purposes has yet to be extended to other family of snakes to be proven useful.

摘要

对七种矛头蝮属物种以及巴西本土特有的三色矛头蝮和巨蝮蛇的混合毒液进行了促凝、蛋白水解、磷脂酶以及血小板促聚集和抑制活性的筛选。正如其他作者所报道的,我们还发现,由于同一属内种间差异不明显,对矛头蝮属蛇毒的电泳和凝胶过滤图谱进行检测不能用于鉴定特定毒液的种类。我们的数据表明,科氏矛头蝮、交替矛头蝮和矛头蝮不具有血小板促聚集活性,对血小板聚集的抑制作用较低,其他活性水平极低或处于中等水平。穆氏矛头蝮、诺维迪矛头蝮和巴西矛头蝮的毒液具有高促凝、血小板促聚集和磷脂酶活性,但其蛋白水解和血小板抑制活性较低。巴西矛头蝮毒液对血小板聚集的抑制作用最强,血小板促聚集活性极低。与所研究的矛头蝮属毒液相比,巨蝮毒液的蛋白水解活性最高,而三色矛头蝮毒液具有显著的高血小板促聚集和磷脂酶活性。在所有毒液中,单独使用2 mM的乙二胺四乙酸(EDTA)可完全抑制蛋白水解活性。相比之下,5 mM的苯甲基磺酰氟的存在部分抑制了所有毒液的酪蛋白水解活性,但巨蝮毒液几乎被该试剂完全阻断。总之,这些数据证实了蝰蛇亚科蛇毒中存在高水平的金属蛋白酶。这些酶中的大多数依赖于Ca2+的存在,而在其活性位点中丝氨酸残基的存在则相对较少。数据表明,仅促凝、偶氮酪蛋白水解和磷脂酶A2活性的存在和水平不能区分所研究的矛头蝮属毒液的种类,特别是对于巴西矛头蝮、穆氏矛头蝮和矛头蝮的情况。然而,低剂量巴西矛头蝮毒液的血小板抑制特性可用于将其与穆氏矛头蝮毒液区分开来。同样,高剂量巴西矛头蝮毒液的血小板促聚集活性可用于将其与矛头蝮粗毒液区分开来,否则它们非常相似但无法激活血小板。总之,我们对生物学特性的比较筛选表明,血小板研究可作为区分在生化行为上非常相似的毒液的一种工具。尽管很有前景,但蛇毒诱导的血小板激活研究在分类或分类学目的方面的普遍适用性还有待扩展到其他蛇类家族以证明其有用性。

相似文献

1
Bothrops sp. snake venoms: comparison of some biochemical and physicochemical properties and interference in platelet functions.矛头蝮属蛇毒:某些生化和理化性质的比较以及对血小板功能的干扰
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Jan;119(1):21-9. doi: 10.1016/s0742-8413(97)00163-1.
2
Identification of bothrojaracin-like proteins in snake venoms from Bothrops species and Lachesis muta.在具窍蝮蛇属物种和巨蝮的蛇毒中鉴定类博特罗贾辛蛋白。
Toxicon. 1999 Oct;37(10):1403-16. doi: 10.1016/s0041-0101(99)00087-2.
3
Antigenic, microbicidal and antiparasitic properties of an l-amino acid oxidase isolated from Bothrops jararaca snake venom.从巴西矛头蝮蛇毒中分离出的一种L-氨基酸氧化酶的抗原性、杀微生物和抗寄生虫特性。
Toxicon. 2009 Mar 1;53(3):330-41. doi: 10.1016/j.toxicon.2008.12.004. Epub 2008 Dec 11.
4
Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract.软毛曼德维拉(夹竹桃科)水提取物对某些蛇毒和毒素的酶活性及药理活性的抑制作用
Biochimie. 2003 Oct;85(10):1017-25. doi: 10.1016/s0300-9084(03)00138-x.
5
Biochemical and pharmacological screening of snake (Bothrops) venoms: characterization of components acting on blood coagulation and platelet aggregation.蛇(矛头蝮属)毒液的生化与药理学筛选:作用于血液凝固和血小板聚集的成分特性
Braz J Med Biol Res. 1988;21(4):763-5.
6
Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom.从矛头蝮蛇毒中分离出的磷脂酶A2对血小板活化的抑制作用机制
Thromb Haemost. 1997 Nov;78(5):1372-80.
7
Partial purification and some physicochemical properties of phospholipases A2 from the venom of the bushmaster snake (Lachesis muta).巨蝮蛇(Lachesis muta)毒液中磷脂酶A2的部分纯化及一些理化性质
Braz J Med Biol Res. 1993 May;26(5):459-63.
8
Prospection, structural analysis and phylogenetic relationships of endogenous gamma-phospholipase A(2) inhibitors in Brazilian Bothrops snakes (Viperidae, Crotalinae).巴西矛头蝮蛇(蝰科,响尾蛇亚科)内源性γ-磷脂酶A2抑制剂的前瞻性研究、结构分析及系统发育关系
Toxicon. 2008 Jul;52(1):122-9. doi: 10.1016/j.toxicon.2008.04.167. Epub 2008 May 29.
9
Bothrops jararaca snake venom: effects on platelet aggregation.巴西矛头蝮蛇毒:对血小板聚集的影响。
Thromb Res. 1990 May 1;58(3):303-16. doi: 10.1016/0049-3848(90)90100-q.
10
Cross-reactivity and heterologous neutralization of crotaline antivenoms used in Argentina.阿根廷使用的响尾蛇抗蛇毒血清的交叉反应性和异源中和作用。
Toxicon. 1998 Jul;36(7):1025-38. doi: 10.1016/s0041-0101(97)00111-6.

引用本文的文献

1
Bothrops venom-induced hemostasis disorders in the rat: Between Scylla and Charybdis.响尾蛇属蛇毒引起的大鼠止血功能障碍:进退维谷。
PLoS Negl Trop Dis. 2023 Nov 27;17(11):e0011786. doi: 10.1371/journal.pntd.0011786. eCollection 2023 Nov.
2
and Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms.蛇毒的体外研究:组成、促凝作用、辅助因子依赖性以及抗蛇毒血清的纠正作用。
Toxins (Basel). 2023 Oct 16;15(10):614. doi: 10.3390/toxins15100614.
3
Bleeding Disorders in Envenomations in the Brazilian Amazon: Participation of Hemostatic Factors and the Impact of Tissue Factor.
《巴西亚马逊地区蛇伤出血性疾病:止血因子的参与及组织因子的影响》
Toxins (Basel). 2020 Aug 29;12(9):554. doi: 10.3390/toxins12090554.
4
, the most important snake involved in human envenomings in the amazon: How venomics contributes to the knowledge of snake biology and clinical toxinology.亚马逊地区导致人类中毒最重要的蛇类:毒液组学如何促进对蛇生物学和临床毒素学的认识。
Toxicon X. 2020 Apr 23;6:100037. doi: 10.1016/j.toxcx.2020.100037. eCollection 2020 Jun.
5
Quality of thrombin produced from the patient's own plasma using the TPD, a new Thrombin-processing Device.使用新型凝血酶处理装置(TPD)从患者自身血浆中产生的凝血酶的质量。
J Extra Corpor Technol. 2005 Jun;37(2):196-200.
6
Medicinal and ethnoveterinary remedies of hunters in Trinidad.特立尼达岛猎人的药用和民族兽医疗法。
BMC Complement Altern Med. 2001;1:10. doi: 10.1186/1472-6882-1-10. Epub 2001 Nov 30.